Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 2, 2026

Tech stocks today: OpenAI strikes deal with Pentagon amid Anthropic feud, Nvidia invests $4B in photonics makers

View original at finance.yahoo.com
Tech stocks today: OpenAI strikes deal with Pentagon amid Anthropic feud, Nvidia invests $4B in photonics makers Artificial intelligence startup OpenAI (OPAI.PVT) said it landed a deal with the Department of Defense over the weekend, coinciding with the US strikes in Iran and coming just after President Trump ordered a…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • CoreWeave capital expenditures will increase from $15.4 billion in 2025 to at least $30 billion in 2026

    80% confidence
  • What we are witnessing is not a temporary squeeze, but a tsunami-like shock originating in the memory supply chain, with ripple effects spreading across the entire consumer electronics industry

    80% confidence
  • Cannot in good conscience accede to Pentagon's request for unrestricted AI model usage

    80% confidence
  • Anthropic would rather cut ties with the government than cross two red lines: using models for mass surveillance of US citizens and using them to develop fully autonomous weapons

    80% confidence
  • Confident in hyperscalers' cash flow growing due to inflection of agentic AI and usefulness of agents across enterprises

    80% confidence
  • This is a simple, common-sense request that will prevent Anthropic from jeopardizing critical military operations and potentially putting our warfighters at risk

    80% confidence
  • Data Center revenue for Q4 was record $62.3 billion, up 75% year-over-year and 22% sequentially, driven by major platform shifts in accelerated computing and AI

    80% confidence
  • Contract language received overnight from DOD made virtually no progress on preventing Claude's use for mass surveillance or fully autonomous weapons, with legalese allowing safeguards to be disregarded

    80% confidence
  • We don't need it, we don't want it, and will not do business with them again

    80% confidence
  • If Anthropic doesn't get their act together and be helpful during phase-out, will use full power of presidency to make them comply with major civil and criminal consequences

    80% confidence
  • OpenAI shares Anthropic's red lines on mass surveillance and autonomous weapons

    80% confidence
  • Computing has fundamentally changed in the age of AI, with software running on intelligence with tokens generated in real time by AI factories

    80% confidence
  • The partnership with OpenAI remains strong and central, with unchanged IP, commercial, revenue-sharing, and AGI processes

    80% confidence
  • DOD has no desire to surveil Americans or develop fully autonomous weapons

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Tech stocks today: OpenAI strikes deal with Pentagon amid Anthropic feud, Nvidia invests $4B in photonics makers — Source | Via News | Via News